CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Clinical trials for CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE trials appear
Sign up with your email to follow new studies for CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for leukemia patients who stopped responding to standard treatments
Disease control Recruiting nowThis early-stage study tests a new drug called ELVN-001 in about 250 adults with chronic myeloid leukemia (CML) whose cancer has stopped responding to or who cannot tolerate other treatments. The main goals are to check the drug's safety and find the best dose. Participants will …
Matched conditions: CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE1 • Sponsor: Enliven Therapeutics • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New vaccine aims to shield stem cell patients from dangerous virus
Prevention Recruiting nowThis early-phase trial tests a vaccine (CMV-MVA Triplex) given to both stem cell donors and recipients to boost immunity against cytomegalovirus (CMV) and prevent active infection after transplant. About 46 people with various blood cancers or disorders will take part. The goal i…
Matched conditions: CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated May 26, 2026 06:16 UTC